Latest ebit for 2329.HK: $-740M, below the sector sector average of $2.4T.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
Glory Health Industry Limited's ebit stands at $-740M as of June 2026. That compares with $-190M in the prior-year period — down 285.3% year over year. That is below the sector sector average of $2.4T. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Glory Health Industry Limited reported $-740M in EBIT versus $-190M a year earlier — a 285.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Glory Health Industry Limited sits lower the its sector benchmark ($2.4T) with a EBIT of $-740M. That is roughly 100.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
That compares with $-190M in the prior-year period — down 285.3% year over year. Sustained growth in EBIT can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Glory Health Industry Limited's EBIT evolved across reporting periods, while the comparison chart places 2329.HK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.